ChemGenes
Pre-clinicalChemGenes is a specialized manufacturer and supplier critical to the nucleic acid synthesis supply chain, positioning itself as a market leader in DNA and RNA manufacturing reagents. The company's extensive product portfolio supports academic research, pharmaceutical development, and biotech innovation worldwide, with a stated mission to accelerate and serve the nucleic acid community. Its strategic focus includes enabling next-generation therapies like those for COVID-19 and participating in major industry events to maintain its leadership position.
Private Company
Funding information not available
AI Company Overview
ChemGenes is a specialized manufacturer and supplier critical to the nucleic acid synthesis supply chain, positioning itself as a market leader in DNA and RNA manufacturing reagents. The company's extensive product portfolio supports academic research, pharmaceutical development, and biotech innovation worldwide, with a stated mission to accelerate and serve the nucleic acid community. Its strategic focus includes enabling next-generation therapies like those for COVID-19 and participating in major industry events to maintain its leadership position.
Technology Platform
Comprehensive manufacturing platform for nucleic acid synthesis, including the broadest range of modified phosphoramidites, solid supports, nucleosides, and specialty reagents for oligonucleotide research and therapeutic development.
Opportunities
Risk Factors
Competitive Landscape
ChemGenes competes with specialized reagent suppliers like Glen Research and large life science conglomerates like MilliporeSigma. Its claimed differentiation is offering the broadest range of modified chemistries, positioning it as a go-to expert for complex, non-standard oligonucleotide synthesis needs in therapeutic development.